Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 May;100(2):239–245. doi: 10.1111/j.1365-2249.1995.tb03660.x

Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections.

A Gaafar 1, A Kharazmi 1, A Ismail 1, M Kemp 1, A Hey 1, C B Christensen 1, M Dafalla 1, A Y el Kadaro 1, A M el Hassan 1, T G Theander 1
PMCID: PMC1534327  PMID: 7743662

Abstract

The T cell response was studied in 25 patients suffering from cutaneous leishmaniasis caused by Leishmania major with severe (n = 10) and mild (n = 15) disease manifestations. Peripheral blood mononuclear cells (PBMC) from the patients were activated by sonicates of Leishmania promastigotes (LMP) and amastigotes (LDA), and the surface protease gp63. The proliferative responses to Leishmania antigens were lower in patients with severe disease than in patients with mild disease (P = 0.01-0.05), and such a difference was not observed in the response to purified protein derivative of tuberculin (PPD) or tetanus toxoid (TT). LMP-induced interferon-gamma (IFN-gamma) production was lower in patients with severe than in patients with mild disease (P < 0.05). When the IL-4 and IFN-gamma responses of each patient were considered, two response patterns were observed in the cultures activated by the Leishmania sonicates. One response pattern was characterized by high production of IFN-gamma without production of IL-4 (a Th1-like pattern), the other was characterized by low IFN-gamma levels which in most cases were associated with IL-4 production (not a Th1-like pattern). These patterns could not be distinguished when the cells from the same donors were stimulated by TT and PPD. The percentages of patients with a Th1-like response pattern after stimulation by LMP in patients with severe and mild disease manifestations were 30% and 80%, respectively. This difference was statistically significant (P = 0.034).

Full text

PDF
245

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akuffo H. O., Britton S. F. Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol. 1992 Jan;87(1):58–64. doi: 10.1111/j.1365-2249.1992.tb06413.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Badaro R., Falcoff E., Badaro F. S., Carvalho E. M., Pedral-Sampaio D., Barral A., Carvalho J. S., Barral-Netto M., Brandely M., Silva L. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma. N Engl J Med. 1990 Jan 4;322(1):16–21. doi: 10.1056/NEJM199001043220104. [DOI] [PubMed] [Google Scholar]
  3. Bouvier J., Etges R. J., Bordier C. Identification and purification of membrane and soluble forms of the major surface protein of Leishmania promastigotes. J Biol Chem. 1985 Dec 15;260(29):15504–15509. [PubMed] [Google Scholar]
  4. Castes M., Agnelli A., Verde O., Rondón A. J. Characterization of the cellular immune response in American cutaneous leishmaniasis. Clin Immunol Immunopathol. 1983 May;27(2):176–186. doi: 10.1016/0090-1229(83)90068-5. [DOI] [PubMed] [Google Scholar]
  5. Castes M., Cabrera M., Trujillo D., Convit J. T-cell subpopulations, expression of interleukin-2 receptor, and production of interleukin-2 and gamma interferon in human American cutaneous leishmaniasis. J Clin Microbiol. 1988 Jun;26(6):1207–1213. doi: 10.1128/jcm.26.6.1207-1213.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cáceres-Dittmar G., Tapia F. J., Sánchez M. A., Yamamura M., Uyemura K., Modlin R. L., Bloom B. R., Convit J. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction. Clin Exp Immunol. 1993 Mar;91(3):500–505. doi: 10.1111/j.1365-2249.1993.tb05931.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Douvas G. S., Looker D. L., Vatter A. E., Crowle A. J. Gamma interferon activates human macrophages to become tumoricidal and leishmanicidal but enhances replication of macrophage-associated mycobacteria. Infect Immun. 1985 Oct;50(1):1–8. doi: 10.1128/iai.50.1.1-8.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frankenburg S., Jonas F., Gross A., Klaus S. Development of in vitro parameters of cell-mediated immunity in the course of human cutaneous leishmaniasis infection. Am J Trop Med Hyg. 1993 Apr;48(4):512–518. doi: 10.4269/ajtmh.1993.48.512. [DOI] [PubMed] [Google Scholar]
  9. Ghalib H. W., Piuvezam M. R., Skeiky Y. A., Siddig M., Hashim F. A., el-Hassan A. M., Russo D. M., Reed S. G. Interleukin 10 production correlates with pathology in human Leishmania donovani infections. J Clin Invest. 1993 Jul;92(1):324–329. doi: 10.1172/JCI116570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Glaser T. A., Wells S. J., Spithill T. W., Pettitt J. M., Humphris D. C., Mukkada A. J. Leishmania major and L. donovani: a method for rapid purification of amastigotes. Exp Parasitol. 1990 Oct;71(3):343–345. doi: 10.1016/0014-4894(90)90039-f. [DOI] [PubMed] [Google Scholar]
  11. Guirges S. Y. Natural and experimental re-infection of man with Oriental sore. Ann Trop Med Parasitol. 1971 Jun;65(2):197–205. doi: 10.1080/00034983.1971.11686746. [DOI] [PubMed] [Google Scholar]
  12. Harms G., Zwingenberger K., Chéhadé A. K., Talhari S., Racz P., Mouakeh A., Douba M., Näkel L., Naiff R. D., Kremsner P. G. Effects of intradermal gamma-interferon in cutaneous leishmaniasis. Lancet. 1989 Jun 10;1(8650):1287–1292. doi: 10.1016/s0140-6736(89)92686-x. [DOI] [PubMed] [Google Scholar]
  13. Heyneman D. Immunology of leishmaniasis. Bull World Health Organ. 1971;44(4):499–514. [PMC free article] [PubMed] [Google Scholar]
  14. Hviid L., Albeck G., Hansen B., Theander T. G., Talbot A. A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells. J Immunol Methods. 1993 Jan 4;157(1-2):135–142. doi: 10.1016/0022-1759(93)90079-m. [DOI] [PubMed] [Google Scholar]
  15. Jaffe C. L., Shor R., Trau H., Passwell J. H. Parasite antigens recognized by patients with cutaneous leishmaniasis. Clin Exp Immunol. 1990 Apr;80(1):77–82. doi: 10.1111/j.1365-2249.1990.tb06444.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kadaro A. Y., Ghalib H. W., Ali M. S., Eltoum I., Ismail A., Gaafar A., Kemp M., Kordofani A. A., Reed S. G., el-Hassan A. M. Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985. Am J Trop Med Hyg. 1993 Jan;48(1):44–49. doi: 10.4269/ajtmh.1993.48.44. [DOI] [PubMed] [Google Scholar]
  17. Karp C. L., el-Safi S. H., Wynn T. A., Satti M. M., Kordofani A. M., Hashim F. A., Hag-Ali M., Neva F. A., Nutman T. B., Sacks D. L. In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma. J Clin Invest. 1993 Apr;91(4):1644–1648. doi: 10.1172/JCI116372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kemp M., Hansen M. B., Theander T. G. Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals. Infect Immun. 1992 Jun;60(6):2246–2251. doi: 10.1128/iai.60.6.2246-2251.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kemp M., Hey A. S., Kurtzhals J. A., Christensen C. B., Gaafar A., Mustafa M. D., Kordofani A. A., Ismail A., Kharazmi A., Theander T. G. Dichotomy of the human T cell response to Leishmania antigens. I. Th1-like response to Leishmania major promastigote antigens in individuals recovered from cutaneous leishmaniasis. Clin Exp Immunol. 1994 Jun;96(3):410–415. doi: 10.1111/j.1365-2249.1994.tb06043.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kemp M., Kurtzhals J. A., Bendtzen K., Poulsen L. K., Hansen M. B., Koech D. K., Kharazmi A., Theander T. G. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis. Infect Immun. 1993 Mar;61(3):1069–1073. doi: 10.1128/iai.61.3.1069-1073.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kemp M., Theander T. G., Handman E., Hey A. S., Kurtzhals J. A., Hviid L., Sørensen A. L., Were J. O., Koech D. K., Kharazmi A. Activation of human T lymphocytes by Leishmania lipophosphoglycan. Scand J Immunol. 1991 Feb;33(2):219–224. doi: 10.1111/j.1365-3083.1991.tb03752.x. [DOI] [PubMed] [Google Scholar]
  22. Kubba R., el-Hassan A. M., Al-Gindan Y., Omer A. H., Kutty M. K., Saeed M. B. Dissemination in cutaneous leishmaniasis. I. Subcutaneous nodules. Int J Dermatol. 1987 Jun;26(5):300–304. doi: 10.1111/j.1365-4362.1987.tb00193.x. [DOI] [PubMed] [Google Scholar]
  23. Kurtzhals J. A., Hansen M. B., Hey A. S., Poulsen L. K. Measurement of antigen-dependent interleukin-4 production by human peripheral blood mononuclear cells. Introduction of an amplification step using ionomycin and phorbol myristate acetate. J Immunol Methods. 1992 Dec 8;156(2):239–245. doi: 10.1016/0022-1759(92)90031-n. [DOI] [PubMed] [Google Scholar]
  24. Kurtzhals J. A., Hey A. S., Jardim A., Kemp M., Schaefer K. U., Odera E. O., Christensen C. B., Githure J. I., Olafson R. W., Theander T. G. Dichotomy of the human T cell response to Leishmania antigens. II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients. Clin Exp Immunol. 1994 Jun;96(3):416–421. doi: 10.1111/j.1365-2249.1994.tb06044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kurtzhals J. A., Hey A. S., Theander T. G., Odera E., Christensen C. B., Githure J. I., Koech D. K., Schaefer K. U., Handman E., Kharazmi A. Cellular and humoral immune responses in a population from the Baringo District, Kenya to Leishmania promastigote lipophosphoglycan. Am J Trop Med Hyg. 1992 Apr;46(4):480–488. doi: 10.4269/ajtmh.1992.46.480. [DOI] [PubMed] [Google Scholar]
  26. Martinez S., Looker D. L., Marr J. J. A tissue culture system for the growth of several species of Leishmania: growth kinetics and drug sensitivities. Am J Trop Med Hyg. 1988 Mar;38(2):304–307. doi: 10.4269/ajtmh.1988.38.304. [DOI] [PubMed] [Google Scholar]
  27. Mosmann T. R., Cherwinski H., Bond M. W., Giedlin M. A., Coffman R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986 Apr 1;136(7):2348–2357. [PubMed] [Google Scholar]
  28. Murray H. W., Rubin B. Y., Rothermel C. D. Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine. J Clin Invest. 1983 Oct;72(4):1506–1510. doi: 10.1172/JCI111107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Pampiglione S., Manson-Bahr P. E., Giungi F., Giunti G., Parenti A., Canestri Trotti G. Studies on Mediterranean leishmaniasis. 2. Asymptomatic cases of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 1974;68(6):447–453. doi: 10.1016/0035-9203(74)90067-4. [DOI] [PubMed] [Google Scholar]
  30. Pirmez C., Yamamura M., Uyemura K., Paes-Oliveira M., Conceiço-Silva F., Modlin R. L. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993 Apr;91(4):1390–1395. doi: 10.1172/JCI116341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sacks D. L., Lal S. L., Shrivastava S. N., Blackwell J., Neva F. A. An analysis of T cell responsiveness in Indian kala-azar. J Immunol. 1987 Feb 1;138(3):908–913. [PubMed] [Google Scholar]
  32. Scott P., Pearce E., Cheever A. W., Coffman R. L., Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol Rev. 1989 Dec;112:161–182. doi: 10.1111/j.1600-065x.1989.tb00557.x. [DOI] [PubMed] [Google Scholar]
  33. el-Safi S. H., Peters W. Studies on the leishmaniases in the Sudan. 1. Epidemic of cutaneous leishmaniasis in Khartoum. Trans R Soc Trop Med Hyg. 1991 Jan-Feb;85(1):44–47. doi: 10.1016/0035-9203(91)90151-n. [DOI] [PubMed] [Google Scholar]
  34. el-Safi S. H., Peters W., el-Toam B., el-Kadarow A., Evans D. A. Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):457–464. doi: 10.1016/0035-9203(91)90218-n. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES